Literature DB >> 27436114

Peptidomics of Acanthoscurria gomesiana spider venom reveals new toxins with potential antimicrobial activity.

Thiago F Abreu1, Bianca N Sumitomo1, Milton Y Nishiyama2, Ursula C Oliveira2, Gustavo H M F Souza3, Eduardo S Kitano2, André Zelanis4, Solange M T Serrano2, Inácio Junqueira-de-Azevedo2, Pedro I Silva2, Alexandre K Tashima5.   

Abstract

Acanthoscurria gomesiana is a Brazilian spider from the Theraphosidae family inhabiting regions of Southeastern Brazil. Potent antimicrobial peptides as gomesin and acanthoscurrin have been discovered from the spider hemolymph in previous works. Spider venoms are also recognized as sources of biologically active peptides, however the venom peptidome of A. gomesiana remained unexplored to date. In this work, a MS-based workflow was applied to the investigation of the spider venom peptidome. Data-independent and data-dependent LC-MS/MS acquisitions of intact peptides and of peptides submitted to multiple enzyme digestions, followed by automated chromatographic alignment, de novo analysis, database and homology searches with manual validations showed that the venom is composed by <165 features, with masses ranging from 0.4-15.8kDa. From digestions, 135 peptides were identified from 17 proteins, including three new mature peptides: U1-TRTX-Agm1a, U1-TRTX-Agm2a and U1-TRTX-Agm3a, containing 3, 4 and 3 disulfide bonds, respectively. The toxins U1-TRTX-Agm1a differed by only one amino acid from U1-TRTX-Ap1a from A. paulensis and U1-TRTX-Agm2a was derived from the genicutoxin-D1 precursor from A. geniculata. These toxins have potential applications as antimicrobial agents, as the peptide fraction of A. gomesiana showed activity against Escherichia coli, Enterobacter cloacae and Candida albicans strains. MS data are available via ProteomeXchange Consortium with identifier PXD003884. BIOLOGICAL SIGNIFICANCE: Biological fluids of the Acanthoscurria gomesiana spider are sources of active molecules, as is the case of antimicrobial peptides and acylpolyamines found in the hemolymphs. The venom is also a potential source of toxins with pharmacological and biotechnological applications. However, to our knowledge no A. gomesiana venom toxin structure has been determined to date. Using a combination of high resolution mass spectrometry, transcriptomics and bioinformatics, we employed a workflow to fully sequence, determine the number of disulfide bonds of mature peptides and we found new potential antimicrobial peptides. This workflow is suitable for complete peptide toxin sequencing when handling limited amount of venom samples and can accelerate the discovery of peptides with potential biotechnological applications.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acanthoscurria gomesiana; Antimicrobial peptide; Peptidomics; Theraphotoxin

Mesh:

Substances:

Year:  2016        PMID: 27436114     DOI: 10.1016/j.jprot.2016.07.012

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  10 in total

1.  Quantitative Peptidomics with Five-plex Reductive Methylation labels.

Authors:  Alexandre K Tashima; Lloyd D Fricker
Journal:  J Am Soc Mass Spectrom       Date:  2017-12-12       Impact factor: 3.109

2.  Comparative gender peptidomics of Bothrops atrox venoms: are there differences between them?

Authors:  Adriana Simizo; Eduardo S Kitano; Sávio S Sant'Anna; Kathleen Fernandes Grego; Anita Mitico Tanaka-Azevedo; Alexandre K Tashima
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-10-07

3.  Differential Metabolism of a Two-Carbon Substrate by Members of the Paracoccidioides Genus.

Authors:  Lilian C Baeza; Fabiana R da Mata; Laurine L Pigosso; Maristela Pereira; Gustavo H M F de Souza; Alexandre S G Coelho; Célia M de Almeida Soares
Journal:  Front Microbiol       Date:  2017-11-27       Impact factor: 5.640

4.  Anti-Helicobacter pylori Properties of the Ant-Venom Peptide Bicarinalin.

Authors:  Jesus Guzman; Nathan Téné; Axel Touchard; Denis Castillo; Haouaria Belkhelfa; Laila Haddioui-Hbabi; Michel Treilhou; Michel Sauvain
Journal:  Toxins (Basel)       Date:  2017-12-29       Impact factor: 4.546

5.  Modern trends in animal venom research - omics and nanomaterials.

Authors:  Yuri N Utkin
Journal:  World J Biol Chem       Date:  2017-02-26

6.  Loxosceles gaucho Spider Venom: An Untapped Source of Antimicrobial Agents.

Authors:  Paula J Segura-Ramírez; Pedro I Silva Júnior
Journal:  Toxins (Basel)       Date:  2018-12-06       Impact factor: 4.546

7.  Comparative compositional and functional analyses of Bothrops moojeni specimens reveal several individual variations.

Authors:  Weslei da Silva Aguiar; Nathália da Costa Galizio; Caroline Serino-Silva; Sávio Stefanini Sant'Anna; Kathleen Fernandes Grego; Alexandre Keiji Tashima; Erika Sayuri Nishiduka; Karen de Morais-Zani; Anita Mitico Tanaka-Azevedo
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

8.  Venomic, Transcriptomic, and Bioactivity Analyses of Pamphobeteus verdolaga Venom Reveal Complex Disulfide-Rich Peptides That Modulate Calcium Channels.

Authors:  Sebastian Estrada-Gomez; Fernanda Caldas Cardoso; Leidy Johana Vargas-Muñoz; Juan Carlos Quintana-Castillo; Claudia Marcela Arenas Gómez; Sandy Steffany Pineda; Monica Maria Saldarriaga-Cordoba
Journal:  Toxins (Basel)       Date:  2019-08-27       Impact factor: 4.546

9.  Crotamine in Crotalus durissus: distribution according to subspecies and geographic origin, in captivity or nature.

Authors:  Lídia J Tasima; Caroline Serino-Silva; Daniela M Hatakeyama; Erika S Nishiduka; Alexandre K Tashima; Sávio S Sant'Anna; Kathleen F Grego; Karen de Morais-Zani; Anita M Tanaka-Azevedo
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-04-06

10.  The Bioflavonoids Rutin and Rutin Succinate Neutralize the Toxins of B. jararaca Venom and Inhibit its Lethality.

Authors:  Ana Teresa Azevedo Sachetto; Jackson Gabriel Miyamoto; Alexandre Keiji Tashima; Ana Olívia de Souza; Marcelo Larami Santoro
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.